PMID- 34377136
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220425
IS  - 1642-395X (Print)
IS  - 2299-0046 (Electronic)
IS  - 1642-395X (Linking)
VI  - 38
IP  - 3
DP  - 2021 Jun
TI  - Depressive, anxiety, stress, and insomnia symptoms in patients with psoriasis: a 
      cross-sectional study.
PG  - 510-519
LID - 10.5114/ada.2020.98726 [doi]
AB  - INTRODUCTION: Assessment of psychological well-being in psoriasis patients is 
      recommended. However, studies evaluating depressive, anxiety, stress, and 
      insomnia symptoms in Arabic patients with psoriasis are lacking. AIM: To quantify 
      levels of psoriasis-related depressive, anxiety, stress, and insomnia symptoms in 
      Arabic patients with psoriasis. MATERIAL AND METHODS: A cross-sectional survey on 
      patients' demographics, disease characteristics, and psychological measures using 
      the Patient Health Questionnaire-9, Generalized Anxiety Disorder 7-item scale, 
      Depression Anxiety Stress Scale-21 (7-item stress subscale), and Insomnia 
      Severity Index. The prevalence and scores of depressive, anxiety, stress, and 
      insomnia symptoms were calculated. Multivariate linear regression models were 
      developed to assess patients' demographics and disease characteristics affecting 
      the psychological measures. RESULTS: The analysis included 223 patients. The 
      patients reported mild levels of depressive, anxiety, and insomnia symptoms 
      (median (interquartile range (IQR)) scores: 9 (6-14), 6 (4-11), and 12 (4-18), 
      respectively) and a moderate level of stress symptoms (median (IQR) score: 10 
      (5-14)). The prevalence of depressive, anxiety, stress, and insomnia symptoms 
      were 47.1%, 32.7%, 59.6%, and 57%, respectively. Multivariate linear regression 
      analyses revealed that for each unit increase in the impact of psoriasis on daily 
      life, there were 5.7 (95% confidence intervals (CI): 3.7-7.8), 3.8 (95% CI: 
      1.8-5.7), 5.3 (95% CI: 3.1-7.4), and 6.5 (95% CI: 3.7-9.4) units increase in 
      depression, anxiety, and stress, and insomnia scores, respectively. CONCLUSIONS: 
      The prevalence of depressive, anxiety, stress, and insomnia symptoms in Arabic 
      patients with psoriasis was high. Clinical interventions, screening for 
      psychiatric comorbidities, and consideration of psychotherapy should be 
      implemented in this patient group.
CI  - Copyright: (c) 2021 Termedia Sp. z o. o.
FAU - Soliman, Moetaza M
AU  - Soliman MM
AD  - Department of Pharmacy Practice, Faculty of Pharmacy, Mansoura University, Egypt.
LA  - eng
PT  - Journal Article
DEP - 20200918
PL  - Poland
TA  - Postepy Dermatol Alergol
JT  - Postepy dermatologii i alergologii
JID - 101168357
PMC - PMC8330873
OTO - NOTNLM
OT  - anxiety
OT  - cross-sectional
OT  - depression
OT  - insomnia
OT  - psoriasis
OT  - stress
COIS- The author declares no conflict of interest.
EDAT- 2021/08/12 06:00
MHDA- 2021/08/12 06:01
PMCR- 2021/06/01
CRDT- 2021/08/11 06:36
PHST- 2020/06/25 00:00 [received]
PHST- 2020/08/05 00:00 [accepted]
PHST- 2021/08/11 06:36 [entrez]
PHST- 2021/08/12 06:00 [pubmed]
PHST- 2021/08/12 06:01 [medline]
PHST- 2021/06/01 00:00 [pmc-release]
AID - 98726 [pii]
AID - 10.5114/ada.2020.98726 [doi]
PST - ppublish
SO  - Postepy Dermatol Alergol. 2021 Jun;38(3):510-519. doi: 10.5114/ada.2020.98726. 
      Epub 2020 Sep 18.